Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 442 of 1,261

  1. US 10562953

    GPR156 variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  2. US 10562941

    Pneumolysin mutants and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  3. US 10562938

    Theragnostic particles

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  4. US 10562930

    Salts and crystal forms of GABAA positive allosteric modulator

    PRAXIS PRECISION MEDICINES, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  5. US 10562960

    Neutralizing antibodies to gp120 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  6. US 10562934

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  7. US 10562894

    Pyrimidine compound as JAK kinase inhibitor

    Theravance Biopharma R&D IP, LLC · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  8. US 10562882

    Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions

    Takeda Pharmaceutical Company Limited · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  9. US 10562970

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  10. US 10561744

    Multi-encapsulated formulations made with oxidized cellulose

    Covidien LP · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  11. US 10562952

    Anti-CD276 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  12. US 10561606

    Injectable long-acting local anesthetic semi-solid gel formulations

    MIRA PHARMA CORPORATION · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  13. US 10561126

    Genetically modified non-human animals and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  14. US 10563259

    Method of treatment based on polymorphisms of the KCNQ1 gene

    VANDA PHARMACEUTICALS INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  15. US 10561662

    4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139

    Takeda Pharmaceutical Company Limited · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  16. US 10561666

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  17. US 10561729

    Near-IR light-cleavable conjugates and conjugate precursors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  18. US 10557118

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  19. US 10556892

    Piperazinyl methanone NAAA inhibitors

    The Regents of the University of California · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  20. US 10555942

    Emetine compounds for treatment and prevention of flavivirus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  21. US 10555964

    Composition and method for promoting reduction of heat stress in animals

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  22. US 10555928

    Cannabis extracts and methods of preparing and using same

    United Cannabis Corp. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  23. US 10555997

    Antigens and vaccines directed against human enteroviruses

    SENTINEXT THERAPEUTICS Sdn Bhd · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  24. US 10556940

    T cell receptors recognizing HLA-Cw8 restricted mutated KRAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.